Class I
Ongoing
Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64
This recall is currently active, issued June 5, 2024. It was issued by Revive Rx Llc Dba Revive Rx Pharmacy.
- Recall Initiated
- April 20, 2024
- Posted
- June 5, 2024
- Recall Number
- D-0511-2024
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 751 vials
- Firm Location
- Houston, TX, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
Distribution
USA Nationwide
Lot / Code Info
Lot #: 748127, Exp 9/24/2024
More recalls by Revive Rx Llc Dba Revive Rx Pharmacy
Other recent Class I Drug recalls
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactu...
Mckesson
· Feb 18, 2026
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLu...
Green Lumber Holdings, Llc
· Feb 11, 2026
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India...
Handelnine Global Llc
· Feb 11, 2026
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNat...
Medinatura New Mexico, Inc.
· Jan 14, 2026
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, L...
Fresenius Kabi Usa, Llc
· Dec 3, 2025